A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers

Chik Z , Basu RC , Pendek R , Lee TC , Mohamed Z
Clin Ther, 2010 Sep;32(10):1822-31.
PMID: 21194606 DOI: 10.1016/j.clinthera.2010.09.006

Abstract

Rifampicin is a semisynthetic antibiotic derivative of rifamycin used worldwide for the treatment of various forms of tuberculosis.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications